Broadwood Capital Inc insider trades: Insight Molecular Diagnostics (IMDX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Broadwood Capital Inc reports to the SEC
and 5 more companies
Open-market buys and sales
170 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | IMDX | ↑ Buy | 521,739 | $5.75 | $3.0M | Direct | Feb 12, 2026 (2d) |
| Jan 9, 2026 | STAA | ↑ Buy | 27,485 | $22.05 | $606K | Direct | Jan 13, 2026 (4d) |
| Jan 8, 2026 | STAA | ↑ Buy | 406,653 | $21.68 | $8.8M | Direct | Jan 8, 2026 (0d) |
| Nov 21, 2025 | STAA | ↑ Buy | 1,500,000 | $27.37 | $41.1M | Direct | Nov 21, 2025 (0d) |
| Apr 10, 2025 | STAA | ↑ Buy | 187,227 | $15.31 | $2.9M | Direct | Apr 10, 2025 (0d) |
| Apr 7, 2025 | STAA | ↑ Buy | 845,220 | $16.12 | $13.6M | Direct | Apr 7, 2025 (0d) |
| Apr 2, 2025 | STAA | ↑ Buy | 53,969 | $17.44 | $941K | Direct | Apr 2, 2025 (0d) |
| Mar 28, 2025 | STAA | ↑ Buy | 113,384 | $17.50 | $2.0M | Direct | Mar 28, 2025 (0d) |
| Mar 25, 2025 | STAA | ↑ Buy | 136,696 | $17.66 | $2.4M | Direct | Mar 25, 2025 (0d) |
| Mar 20, 2025 | STAA | ↑ Buy | 201,844 | $17.77 | $3.6M | Direct | Mar 20, 2025 (0d) |
| Mar 4, 2025 | STAA | ↑ Buy | 27,953 | $17.24 | $482K | Direct | Mar 6, 2025 (2d) |
| Mar 3, 2025 | STAA | ↑ Buy | 663,761 | $16.99 | $11.3M | Direct | Mar 3, 2025 (0d) |
| Feb 14, 2025 | STAA | ↑ Buy | 411,430 | $15.25 | $6.3M | Direct | Feb 14, 2025 (0d) |
| Feb 6, 2025 | OCX | ↑ Buy | 5,165,695 | $2.05 | $10.6M | Direct | Feb 10, 2025 (4d) |
| Jan 27, 2025 | LCTX | ↑ Buy | 7,894,737 | $0.76 | $6.0M | Direct | Jan 28, 2025 (1d) |
| Jan 16, 2025 | STAA | ↑ Buy | 29,376 | $21.47 | $631K | Direct | Jan 16, 2025 (0d) |
| Dec 18, 2024 | STAA | ↑ Buy | 80,200 | $24.28 | $1.9M | Direct | Dec 18, 2024 (0d) |
| Oct 2, 2024 | OCX | ↑ Buy | 1,315,339 | $2.95 | $3.9M | Direct | Oct 4, 2024 (2d) |
| May 9, 2024 | STAA | ↑ Buy | 1 | $42.56 | $43 | Direct | May 13, 2024 (4d) |
| Apr 11, 2024 | OCX | ↑ Buy | 2,420,000 | $2.92 | $7.1M | Direct | Apr 15, 2024 (4d) |
| Feb 6, 2024 | LCTX | ↑ Buy | 6,730,770 | $1.04 | $7.0M | Direct | Feb 8, 2024 (2d) |
| Jan 8, 2024 | STAA | ↑ Buy | 4,042 | $27.11 | $110K | Direct | Jan 10, 2024 (2d) |
| Jan 5, 2024 | STAA | ↑ Buy | 226,553 | $28.61 | $6.5M | Direct | Jan 5, 2024 (0d) |
| Nov 30, 2023 | STAA | ↑ Buy | 434,991 | $31.50 | $13.7M | Direct | Nov 30, 2023 (0d) |
| Nov 13, 2023 | STAA | ↑ Buy | 34,827 | $32.74 | $1.1M | Direct | Nov 14, 2023 (1d) |
| Nov 9, 2023 | STAA | ↑ Buy | 289,140 | $33.42 | $9.7M | Direct | Nov 9, 2023 (0d) |
| Nov 6, 2023 | STAA | ↑ Buy | 309,154 | $34.93 | $10.8M | Direct | Nov 6, 2023 (0d) |
| Oct 6, 2023 | STAA | ↑ Buy | 205,296 | $37.81 | $7.8M | Direct | Oct 6, 2023 (0d) |
| Sep 21, 2023 | STAA | ↑ Buy | 291,383 | $40.12 | $11.7M | Direct | Sep 21, 2023 (0d) |
| Sep 7, 2023 | STAA | ↑ Buy | 189,962 | $41.42 | $7.9M | Direct | Sep 7, 2023 (0d) |
| Apr 3, 2023 | OCX | ↑ Buy | 26,827,638 | $0.30 | $8.1M | Direct | Apr 5, 2023 (2d) |
| Dec 29, 2022 | STAA | ↑ Buy | 191,075 | $47.42 | $9.1M | Direct | Dec 29, 2022 (0d) |
| Apr 14, 2022 | OCX | ↑ Buy | 6,003,752 | $1.33 | $8.0M | Direct | Apr 15, 2022 (1d) |
| Mar 25, 2022 | LCTX | ↑ Buy | 930,106 | $1.42 | $1.3M | Direct | Mar 25, 2022 (0d) |
| Jun 28, 2021 | STAA | ↓ Sell | 228,443 | $156.06 | $35.7M | Direct | Jun 28, 2021 (0d) |
| Jun 18, 2021 | STAA | ↓ Sell | 107,675 | $150.16 | $16.2M | Direct | Jun 21, 2021 (3d) |
| Jun 15, 2021 | STAA | ↓ Sell | 59,550 | $147.57 | $8.8M | Direct | Jun 15, 2021 (0d) |
| Jun 1, 2021 | STAA | ↓ Sell | 266,278 | $146.71 | $39.1M | Direct | Jun 1, 2021 (0d) |
| Apr 26, 2021 | STAA | ↓ Sell | 117,906 | $133.61 | $15.8M | Direct | Apr 26, 2021 (0d) |
| Feb 12, 2021 | STAA | ↓ Sell | 37,451 | $124.42 | $4.7M | Direct | Feb 12, 2021 (0d) |
| Feb 9, 2021 | STAA | ↓ Sell | 257,619 | $121.59 | $31.3M | Direct | Feb 9, 2021 (0d) |
| Feb 5, 2021 | OCX | ↑ Buy | 600,000 | $4.50 | $2.7M | Direct | Feb 9, 2021 (4d) |
| Feb 4, 2021 | STAA | ↓ Sell | 60,861 | $111.00 | $6.8M | Direct | Feb 4, 2021 (0d) |
| Jan 28, 2021 | STAA | ↓ Sell | 789,883 | $103.91 | $82.1M | Direct | Jan 28, 2021 (0d) |
| Jan 20, 2021 | OCX | ↑ Buy | 1,460,280 | $3.42 | $5.0M | Direct | Jan 22, 2021 (2d) |
| Jan 12, 2021 | STAA | ↓ Sell | 60,000 | $89.28 | $5.4M | Direct | Jan 12, 2021 (0d) |
| Apr 24, 2020 | OCX | ↑ Buy | 1,050,000 | $2.27 | $2.4M | Direct | Apr 28, 2020 (4d) |
| Jan 2, 2020 | OCX | ↑ Buy | 1,391,466 | $2.16 | $3.0M | Direct | Jan 6, 2020 (4d) |
| Nov 13, 2019 | OCX | ↑ Buy | 1,176,471 | $1.70 | $2.0M | Direct | Nov 15, 2019 (2d) |
| Sep 11, 2019 | OCX | ↑ Buy | 2,000,000 | $1.66 | $3.3M | Direct | Sep 13, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMDX insiders
Open-market trades in the last 12 months
About Broadwood Capital Inc's insider trades
Broadwood Capital Inc is a 10% owner of Insight Molecular Diagnostics (IMDX). Since Jan 9, 2007, it has reported 150 open-market purchases worth $341.3M and 20 sales worth $347.1M on SEC Form 4. In the last 12 months: 4 buys ($53.5M).
Its filings also include other transactions (32 filings), option exercises (9 filings), grants and awards (7 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.